Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Galantamine and Donepezil on the Amount and the Quality on the Sleep in Patients Suffering From Alzheimer Disease.

Next Previous
Trial Profile

Effects of Galantamine and Donepezil on the Amount and the Quality on the Sleep in Patients Suffering From Alzheimer Disease.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Donepezil (Primary) ; Galantamine (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacodynamics

Most Recent Events

  • 04 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
  • 03 Sep 2013 Planned end date changed from 1 Sep 2009 to 1 Sep 2014 as reported by ClinicalTrials.gov.
  • 25 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top